Researchers at Henan Province Eye Hospital in China have made great strides in studying endotoxin-induced uveitis (EIU) by creating a novel EIU model in zebrafish. Uveitis is an ocular inflammation and one of the main causes of visual impairment, accounting for 10-15% of global blindness. Mice have typically been the research animal of choice however
11.07
2023
Researchers find early signs of Alzheimer’s disease (AD) in the mouse retina and develop a non-invasive artificial intelligence-based system that could be used to diagnose the disease before the appearance of clinical symptoms
Progress in diagnosing and treating Alzheimer’s disease (AD) has been accelerating over the last few years. Until now, AD has been difficult to diagnose. The disease can be present years before distinguishable symptoms manifest. Non-invasive diagnostic tests have been lacking, and diagnosis often relies on memory, cognitive, and behavioral tests. In 2011, Koronyo-Hamaoui M, Koronyo
21.04
2023
Phoenix-Micron, Inc. launches the next generation of its MICRON in vivo ophthalmic imaging platform for small animal research
The all-new MICRON® 5 platform delivers advanced performance, repeatability, and imaging workflow efficiency Bend, OR, USA, April 21, 2023 – Phoenix-Micron, Inc. today announced the launch of the all-new Phoenix MICRON® 5 imaging system, the latest breakthrough in small animal ophthalmic imaging technology. With over 450 published studies utilizing MICRON imaging systems, the MICRON platform
21.04
2023
Phoenix-Micron, Inc. Announces New, Comprehensive Imaging Software and Redesigned Lens Technology for the Phoenix MICRON® Imaging Platform
Two new innovations, MICRON Software Suite and MICRON LT2 lens technology, streamline the ophthalmic imaging workflow and deliver new data management capabilities. Bend, OR, USA, April 21, 2023– Phoenix-Micron, Inc., a leader in ophthalmic imaging technology, today announced the release of the new MICRON® Software Suite and the MICRON LT2 lens technology. The new
08.03
2023
Researchers at the University of Copenhagen demonstrate for the first time that diet induced obesity (DIO) leads to raised intracranial pressure (ICP) and subsequent clinically relevant symptom development.
In the paper “The impact of obesity‑related raised intracranial pressure in rodents” published in Scientific Reports journal, Westgate and collaborators used the Phoenix MICRON® image-guided OCT system, along with the Phoenix MICRON® Insight software, in the measurement of the retinal anatomical changes caused by intracranial hypertension in obese rats. The Problem: Intracranial pressure (ICP) measures the
29.11
2021
Phoenix MICRON Spins out of Phoenix Technology Group to Better Serve Eye and Eye-Brain Researchers Globally
Bend, OR, USA, November 29, 2021 — The newly formed company, Phoenix-Micron, Inc., announced today it has completed the spin-out of the Phoenix MICRON® imaging platform from Phoenix Technology Group. This move is designed to increase focus and innovation in products designed to serve the eye and eye-brain research community. The new company, Phoenix-Micron, Inc.